Daewoong Pharmaceutical's affiliate, M Circle, showcased a fully automated administrative process for primary care chronic disease management, significantly reducing operational burdens. Over 5,600 healthcare professionals participated in the online seminar, demonstrating high interest in practical applications.
On June 24, M Circle announced that it shared a case study on primary care chronic disease management led by Lee Dae-geun, director of Seoul Jeongtong Union Clinic, during an online seminar hosted on the medical platform Dr. Bill. The seminar aimed to introduce patient management cases utilizing the digital healthcare platform Wellcheck in primary care settings.
During the seminar, Lee discussed his experiences and outcomes from implementing the "Wellcheck-based primary care chronic disease management program." The Seoul Jeongtong Union Clinic has established personalized care plans for patients and continuously monitors blood pressure and blood sugar data. This approach has improved the continuity of patient management while reducing administrative burdens.
The primary care chronic disease management program, operated by the Ministry of Health and Welfare and the Health Insurance Review and Assessment Service, allows local clinics to act as primary care providers, creating annual management plans for patients with hypertension and diabetes while providing education, counseling, and monitoring. Currently, primary care institutions nationwide can participate.
Wellcheck is a platform that integrates and manages patient health data, enabling healthcare professionals to utilize this information in their practice. It enhances patient engagement through features such as monitoring based on patient records and providing educational materials. The entire process, from sending patient invitations to automated consent forms, collecting questionnaires, creating care plans, and evaluations, has been digitized. It also supports the automatic compilation of materials for submission to the Health Insurance Review and Assessment Service.
Lee stated, "The use of Wellcheck has significantly reduced administrative burdens, and both patient and healthcare professional satisfaction have increased due to continuous monitoring of health data."
The seminar also highlighted the benefits for patients participating in the chronic disease management program. Participants can receive financial support of up to 80,000 won annually through a health promotion support program, along with reduced out-of-pocket expenses.
The operational benefits for healthcare institutions were also presented. According to the presentation, utilizing the fee structure of the program could allow for additional billing of up to 380,000 won per patient. If the program is operated with 500 patients, additional monthly revenue exceeding 10 million won is anticipated.
Lee added, "I hope more healthcare institutions will utilize digital healthcare platforms to enhance the quality of chronic disease management and provide patient-centered medical services."
Meanwhile, Daewoong Pharmaceutical plans to advance its digital healthcare open innovation strategy. Last year, M Circle launched the 'Wellcheck-Egis Chart' integration service, which automatically links electronic medical record (EMR) systems.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.